ABFERO Trademark

Trademark Overview


On Monday, November 28, 2022, a trademark application was filed for ABFERO with the United States Patent and Trademark Office. The USPTO has given the ABFERO trademark a serial number of 79361488. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, March 14, 2024. This trademark is owned by Pharmacosmos Holding A/S. The ABFERO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in humans; veterinary preparations for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in animals; dietary supplements for human beings and animals; iron preparations for pharmaceutical use being nutritional supplements; iron preparations for veterinary use being nutritional supplements; iron preparations as dietary supplements; diagnostic preparations for medical and veterinary purposes; molecular weight testing reagents for diagnostic purposes; medicinal, pharmaceutical and veterinary preparations for parenteral administration, in particular oral, intravenous, intramuscular and subcutaneous for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in humans; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment and prevention of iron deficiency and/or anaemia or of iron overlo...
abfero

General Information


Serial Number79361488
Word MarkABFERO
Filing DateMonday, November 28, 2022
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, March 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements


Goods and ServicesPharmaceuticals for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in humans; veterinary preparations for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in animals; dietary supplements for human beings and animals; iron preparations for pharmaceutical use being nutritional supplements; iron preparations for veterinary use being nutritional supplements; iron preparations as dietary supplements; diagnostic preparations for medical and veterinary purposes; molecular weight testing reagents for diagnostic purposes; medicinal, pharmaceutical and veterinary preparations for parenteral administration, in particular oral, intravenous, intramuscular and subcutaneous for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in humans; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment and prevention of iron deficiency and/or anaemia or of iron overload in humans; chemical preparations for veterinary purposes, namely, for the treatment and prevention of iron deficiency and/or anaemia or of iron overload in humans

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateFriday, February 3, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePharmacosmos Holding A/S
Party Type10 - Original Applicant
Legal Entity Type65 - NOT AVAILABLE
AddressDK

Trademark Events


Event DateEvent Description
Wednesday, April 3, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 3, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 13, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, March 13, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 13, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, March 13, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, February 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 13, 2023REFUSAL PROCESSED BY IB
Monday, August 21, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, August 21, 2023REFUSAL PROCESSED BY MPU
Thursday, July 27, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 26, 2023NON-FINAL ACTION WRITTEN
Tuesday, July 18, 2023ASSIGNED TO EXAMINER
Tuesday, February 7, 2023APPLICATION FILING RECEIPT MAILED
Friday, February 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 2, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB